Position in MDGL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$114,846,087
+$478,588 QoQ
Shares Held
213,886
+8.9% QoQ
Ownership
0.926%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 411 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. MDGL ranks #20 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in MDGL
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $114,846,087 | 213,886 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $114,367,499 | 196,393 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $53,405,972 | 176,467 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $31,134,626 | 93,997 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $35,513,938 | 115,092 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $14,849,882 | 69,974 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $32,506,124 | 116,027 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $24,020,248 | 89,950 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $33,686,382 | 145,589 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $22,088,257 | 151,248 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $31,279,017 | 135,407 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $28,245,335 | 116,591 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $33,756,075 | 116,300 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,558,337 | 116,300 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $7,838,439 | 109,506 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $10,744,728 | 109,506 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $9,279,538 | 109,506 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $8,059,268 | 101,006 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $7,175,123 | 73,659 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $12,465,025 | 106,566 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $16,618,580 | 149,488 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $18,935,297 | 159,482 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $16,057,491 | 141,788 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $8,855,847 | 132,652 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||